Evidence map›Paper›PMID 39640709›Full record

ArticleHeliyon2024

Plasma C24:0 ceramide impairs adipose tissue remodeling and promotes liver steatosis and glucose imbalance in offspring of rats.

Alberto Camacho-Morales, Lilia G Noriega, Adriana Sánchez-García, Ivan Torre-Villalvazo, Natalia Vázquez-Manjarrez, Roger Maldonado-Ruiz, Marcela Cárdenas-Tueme, Mariana Villegas-Romero, Itzayana Alamilla-Martínez, Humberto Rodriguez-Rocha and 7 more

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Observational
  5. The Role of Ceramides in Metabolic and Cardiovascular Diseases.Journal of cardiovascular development and disease · 2026
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Alberto Camacho-MoralesBiochemistry and Molecular Medicine Department, College of Medicine, Autonomous University of Nuevo Leon, Monterrey, Mexico.
Lilia G NoriegaNutrition Physiology Department, National Institute of Medical Sciences and Nutrition. México City, Mexico.
Adriana Sánchez-GarcíaUniversity Hospital "Dr. Jose E. Gonzalez, Endocrinology Division. Department of Internal Medicine. Autonomous University of Nuevo Leon Monterrey, Mexico.
Ivan Torre-VillalvazoNutrition Physiology Department, National Institute of Medical Sciences and Nutrition. México City, Mexico.
Natalia Vázquez-ManjarrezNutrition Physiology Department, National Institute of Medical Sciences and Nutrition. México City, Mexico.
Roger Maldonado-RuizBiochemistry and Molecular Medicine Department, College of Medicine, Autonomous University of Nuevo Leon, Monterrey, Mexico.
Marcela Cárdenas-TuemeFacultad de Salud Pública y Nutrición, Centro de Investigación en Nutrición y Salud Pública, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Mariana Villegas-RomeroNutrition Physiology Department, National Institute of Medical Sciences and Nutrition. México City, Mexico.
Itzayana Alamilla-MartínezNutrition Physiology Department, National Institute of Medical Sciences and Nutrition. México City, Mexico.
Humberto Rodriguez-RochaHistology Department, College of Medicine, Autonomous University of Nuevo Leon, Monterrey, Mexico.
Aracely Garcia-GarciaHistology Department, College of Medicine, Autonomous University of Nuevo Leon, Monterrey, Mexico.
Juan Carlos CoronaNeuroscience Laboratory, Hospital Infantil de México, Federico Gómez, México City, Mexico.
Armando R TovarNutrition Physiology Department, National Institute of Medical Sciences and Nutrition. México City, Mexico.
Jennifer SavilleGenetics and Molecular Pathology, SA Pathology at Women's and Children's Hospital, University of Adelaide, Australia.
Maria FullerGenetics and Molecular Pathology, SA Pathology at Women's and Children's Hospital, University of Adelaide, Australia.
José Gerardo Gonzalez-GonzalezUniversity Hospital "Dr. Jose E. Gonzalez, Endocrinology Division. Department of Internal Medicine. Autonomous University of Nuevo Leon Monterrey, Mexico.
Ana María Rivas-EstillaBiochemistry and Molecular Medicine Department, College of Medicine, Autonomous University of Nuevo Leon, Monterrey, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fetal programming by exposure to high-energy diets increases the susceptibility to type 2 diabetes mellitus (T2DM2) in the offspring. Glucose imbalance during fetal programming might be associated to still unknown selective lipid species and their characterization might be beneficial for T2DM diagnosis and treatment. We aim to characterize the effect of the lipid specie, C24:0 ceramide, on glucose imbalance and metabolic impairment in cellular and murine models. A lipidomic analysis identified accumulation of C24:0 ceramide in plasma of offspring rats exposed to high-energy diets during fetal programing, as well as in obese-T2DM subjects.

Indexed as

Adipose tissue remodelingC24:0 ceramideDiabetesER stressfetal programmingmitochondria

Identifiers

PMID39640709
PMCPMC11620212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.